Pacira Pharmaceuticals Stock Forecast - Period Momentum Indicator

PCRX Stock  USD 27.21  0.71  2.68%   
Pacira Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pacira Pharmaceuticals stock prices and determine the direction of Pacira Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pacira Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Pacira Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Pacira Pharmaceuticals' systematic risk associated with finding meaningful patterns of Pacira Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Pacira Pharmaceuticals to cross-verify your projections.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
  
At this time, Pacira Pharmaceuticals' Inventory Turnover is fairly stable compared to the past year. Payables Turnover is likely to rise to 16.18 in 2024, whereas Fixed Asset Turnover is likely to drop 1.63 in 2024. . Net Income Applicable To Common Shares is likely to rise to about 19.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 35.9 M in 2024.

Open Interest Against 2024-05-17 Pacira Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Pacira Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Pacira Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Pacira Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Pacira Pharmaceuticals' open interest, investors have to compare it to Pacira Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Pacira Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Pacira. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Pacira Pharmaceuticals has current Period Momentum Indicator of 0.71.
Most investors in Pacira Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Pacira Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Pacira Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Pacira Pharmaceuticals VolatilityBacktest Pacira PharmaceuticalsInformation Ratio  

Pacira Pharmaceuticals Trading Date Momentum

On May 07 2024 Pacira Pharmaceuticals was traded for  27.21  at the closing time. The top price for the day was 27.77  and the lowest listed price was  27.05 . There was no trading activity during the period 0.0. Lack of trading volume on May 7, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.73% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Pacira Pharmaceuticals to competition

Other Forecasting Options for Pacira Pharmaceuticals

For every potential investor in Pacira, whether a beginner or expert, Pacira Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pacira Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pacira. Basic forecasting techniques help filter out the noise by identifying Pacira Pharmaceuticals' price trends.

Pacira Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pacira Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Pacira Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Pacira Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pacira Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pacira Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pacira Pharmaceuticals' current price.

Pacira Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Pacira Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacira Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pacira Pharmaceuticals stock market strength indicators, traders can identify Pacira Pharmaceuticals entry and exit signals to maximize returns.

Pacira Pharmaceuticals Risk Indicators

The analysis of Pacira Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pacira Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pacira stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pacira Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pacira Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacira Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacira Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacira Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Pacira Pharmaceuticals to cross-verify your projections.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Pacira Stock analysis

When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.291
Earnings Share
0.87
Revenue Per Share
14.603
Quarterly Revenue Growth
0.054
Return On Assets
0.0335
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.